Beta
Back to ABBV.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

ABBV Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q4'25, ABBV's total operating expenses reached $6.47B USD, with R&D expenses at $2.58B USD and SG&A expenses at $3.90B USD, marking a notable increase from the prior quarter and reflecting heightened investments in research and administrative functions. Over the period from Q1'23 to Q4'25, R&D expenses exhibited an overall upward trend, starting at $2.29B USD and rising steadily to $2.58B USD, with a brief dip in Q2'23-Q3'23 before consistent growth, including a sharp anomaly in Q4'24 at $6.77B USD possibly due to one-time charges. SG&A expenses remained relatively stable around $3.2B-$3.4B USD through 2023 and early 2024, before surging to $4.21B USD in Q3'24 and climbing further to $3.90B USD by Q4'25, indicating expanding operational scale; the stacked bar chart highlights SG&A as the dominant component, comprising over 60% of total expenses in most quarters.